SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma inks MoU with Invent Pharma

12 Mar 2012 Evaluate

Anuh Pharma has entered into a Memorandum of Understanding (MoU) with Invent Pharma, to acquire fixed assets of latter’s research and development laboratory situated in a leased premise in TTC Industrial Area, Navi Mumbai. The company is also mulling to intensify its own research and development activity with a view to enlarge its bulk drugs portfolio.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Share Price

82.30 -1.85 (-2.20%)
11-May-2026 10:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.00
Dr. Reddys Lab 1283.90
Cipla 1336.45
Zydus Lifesciences 939.65
Lupin 2250.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×